FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/093187 [Registered on: 18/08/2025] Trial Registered Prospectively
Last Modified On: 18/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Single Arm Study 
Public Title of Study   study of features of warts to predict how well it responds to standard treatment using a special magnifying lens to find signs that show which warts will improve with treatment  
Scientific Title of Study   Dermoscopic predictors of treatment response in cutaneous warts: A Prospective Observational Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Niveditha Amarnath 
Designation  Junior resident 
Affiliation  KASTURBA MEDICAL COLLEGE MANIPAL 
Address  Room 22 Department of Dermatology, venereology leprosy OPD Block Manipal academy of higher education Madhav Nagar Manipal Karnataka 576104

Udupi
KARNATAKA
576104
India 
Phone  9845551450  
Fax    
Email  niveditha.kmcmpl2024@learner.manipal.edu  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sathish Pai B 
Designation  Professor 
Affiliation  Kasturba Medical College, Manipal 
Address  Room 22 OPD Block Department of Dermatology Venereology and Leprosy Kmc manipal Manipal academy of higher education Manipal karnataka

Udupi
KARNATAKA
576104
India 
Phone  9900405072  
Fax    
Email  sb.pai@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Sathish Pai B 
Designation  Professor 
Affiliation  Kasturba Medical College, Manipal 
Address  Room 22 OPD Block Department of Dermatology Venereology and Leprosy Kmc manipal Manipal academy of higher education Manipal karnataka

Udupi
KARNATAKA
576104
India 
Phone  9900405072  
Fax    
Email  sb.pai@manipal.edu  
 
Source of Monetary or Material Support  
Nil 
 
Primary Sponsor  
Name  Self 
Address  Room 22 Departmemt of Dermatology Venereology and Leprosy Kmc manipal Manipal academy of higher education Madhav nagar Manipal Karnataka  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Niveditha Amarnath  Kasturba Medical College, Manipal  Department of dermatology venereology and Leprosy Room 22 Opd block
Udupi
KARNATAKA 
9845551450

niveditha.kmcmpl2024@learner.manipal.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba Hospital Institutional Ethics Committee - 2 (Student Research)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: B079||Viral wart, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  12.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Newly diagnosed cutaneous warts
Age older than 12
Common and plantar warts
Undergoing Cryotherapy with parring if required
Using Topical keratolytic such as salicylic acid
Undergoing immunotherapy such as PPD MMR or vitamin D
Combination of these treatments  
 
ExclusionCriteria 
Details  Immunosuppressed patient due to HIV cancer or immunosuppressive medications
Lacking initial or follow up clinical and dermoscopic images
Did not complete the planned treatment  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
treatment response to therapy suggested by the clinician, which will be evaluated both clinically and through dermoscopic images  at baseline, and every follow up visit until lesion clearance or 5 follow ups, whichever earlier.  
 
Secondary Outcome  
Outcome  TimePoints 
how specific dermoscopic features (such as the presence of dots, marked surface scales, and well-defined margins) correlated with these response categories  First visit and every follow up until 5 visits or lesion clearance 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   29/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study aims to determine whether dermoscopic features such as vascular patterns surface scale characteristics and margin definition can predict treatment outcomes in cutaneous warts. The study involves capturing standardized clinical and dermoscopic images before and after treatment including cryotherapy with parring and immunotherapy with intralesional PPD MMR and vitamin D. Topical keratolytic like salicylic acid application in between each of the follow ups will also be included. Each lesions will be followed for five visits or until lesion clearance whichever occurs earlier. Dermoscopic findings will be classified and correlated with treatment response. The objective is to validate dermoscopy as a predictive tool to improve treatment planning and minimize unnecessary sessions. The study addresses the current challenge of variable treatment response and aims to optimize patient care. 
Close